-transparent.png){kind=logo}
The human CYP3A subfamily is of interest due to its multiplicity, activity toward known carcinogens, and extrahepatic expression. In situ hybridisation analysis of formalin fixed, routinely processed biopsy specimens was used to localise CYP3A mRNA in human gastrointestinal tissues from several individuals. CYP3A mRNA is abundant in human liver and in mucosal epithelial cells of all segments of the human small intestine. RNA blot analyses showed that the mRNA species observed in most livers and in human small intestine represent CYP3A3/3A4 transcripts. This was confirmed at the protein level by immunoblot comparison of small intestine microsomes to in vitro expressed CYP3A4 and CYP3A5 proteins. In liver and small intestine, CYP3A mRNA is not uniformly distributed, with grain density highest in cells within the respective non-proliferative compartments. CYP3A mRNA was also observed in human oesophagus and colon. RNA blot analysis of multiple colons showed heterogeneity in the CYP3A mRNAs present. Two CYP3A mRNAs (CYP3A3/3A4 and CYP3A5) were detected in colon samples from several individuals. In addition to those localisation studies, the capacity of expressed CYP3A4 and CYP3A5 to activate the dietary heterocyclic amine MeIQ in the presence of alpha-naphthoflavone was shown. These results show that there is considerable heterogeneity in the expression of the CYP3A subfamily in human gastrointestinal tissues.
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
December 2010,
Animal genetics,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
January 2000,
Drug metabolism reviews,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
October 1994,
Pharmacogenetics,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
July 1990,
Carcinogenesis,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
November 2011,
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
August 2008,
Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
August 2011,
Gene,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
February 2005,
Biological & pharmaceutical bulletin,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
January 1999,
Hepato-gastroenterology,
R A McKinnon, and
W M Burgess, and
P M Hall, and
S J Roberts-Thomson, and
F J Gonzalez, and
M E McManus
March 1997,
Xenobiotica; the fate of foreign compounds in biological systems,
